Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
2.
Acta Gastroenterol Belg ; 82(1): 75-82, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-30888758

RESUMEN

Pruritus is a common, troublesome symptom in patients with cholestatic liver diseases, especially frequent in intrahepatic cholestasis of pregnancy (ICP) and in primary biliary cholangitis (PBC). Cholestatic associated pruritus can have profound effects on the quality of life. The underlying mechanism is still poorly understood. Severe potential pruritogens have been discussed, such as bile salts, opioids, steroid and lysophosphatidic acid (LPA), but none of these are considered as key mediators. Because of this unraveling pathophysiology the treatment of hepatogenic pruritus often represents a clinical challenge. The EASL guidelines have suggested a step-wise approach, starting with elimination of pruritogens by bile acid sequestrants (cholestyramine), in second line managing the metabolism of pruritogens (rifampicin) and in third-line and fourth- line by modifying the itch perception with µ-opioid antagonist or selective serotonin reuptake inhibitors (SSRI). In treatment-refractory pruritus interruption of the enterohepatic cycle by molecular absorbent recirculating system (MARS), nasobiliairy drainage or experimental therapy such as Ultraviolet B light therapy can be considered. Liver transplantation may be reserved for intractable pruritus. Clinical trials with novel agents are ongoing, potentially providing efficacious options in the future.


Asunto(s)
Colestasis/complicaciones , Prurito/complicaciones , Colestasis/psicología , Colestasis Intrahepática , Resina de Colestiramina , Femenino , Humanos , Embarazo , Prurito/psicología , Calidad de Vida
3.
Acta Gastroenterol Belg ; 82(4): 529-531, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31950809

RESUMEN

Persisting suture dehiscence with oesophageal anastomotic leaks after thoracic surgery is a difficult complication, especially when a surgical repair fails. We report here endoscopic vacuum-assisted closure therapy as a novel endoscopic treatment for the management of oesophageal anastomotic leaks. Endoscopic vacuum-assisted closure therapy is a minimally invasive method to treat anastomotic leakage by positioning an open-pored polyurethane sponge and a suction tube connected to a wound drainage system into the opening of the wound cavity. This multidisciplinary endoscopic and surgical approach is a successful therapy for the management of suture dehiscence with oesophageal anastomotic leaks after thoracic surgery or oesophageal perforations.


Asunto(s)
Fuga Anastomótica/terapia , Endoscopía Gastrointestinal/métodos , Perforación del Esófago/terapia , Gastrectomía/efectos adversos , Terapia de Presión Negativa para Heridas , Complicaciones Posoperatorias/cirugía , Anastomosis Quirúrgica , Endoscopía , Humanos , Cirugía Torácica , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...